Abeona Therapeutics Inc (ABEO)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Timothy J. Miller
Employees:
83
3333 LEE PARKWAY, SUITE 600, DALLAS, TX 75219
2149055100

Abeona Therapeutics, Inc. operates as an emerging pharmaceutical company engaged in the development of novel therapeutics for the treatment of cancer and supportive care of cancer patients. It focuses on developing a range of pharmaceutical and medical device products primarily based upon nanopolymer chemistry technologies and other drug delivery technologies. The company's products are ProctiGard, LexaGard, CobOral and CobaCyte. Abeona Therapeutics was founded in 1974 and is headquartered in Dallas, TX.

Data derived from most recent annual or quarterly report
Market Cap 87.055 Million Shares Outstanding101.227 Million Avg 30-day Volume 798.665 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-2.15
Price to Revenue31.4986 Debt to Equity0.0 EBITDA-33.382 Million
Price to Book Value2.6665 Operating Margin-358.9646 Enterprise Value217.946 Million
Current Ratio7.516 EPS Growth0.721 Quick Ratio6.953
1 Yr BETA 52-week High/Low 3.79 / 0.84 Profit Margin-363.205
Operating Cash Flow Growth-45.7097 Altman Z-Score13.1882 Free Cash Flow to Firm -55.319 Million
View SEC Filings from ABEO instead.

View recent insider trading info

Funds Holding ABEO (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ABEO BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

150.5 Thousand total shares from 6 transactions

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

SESHADRI VISHWAS CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
650,000 2021-10-15 3

O'MALLEY BRENDAN M. SVP, GENERAL COUNSEL

  • Officer
222,510 2021-10-11 4

CARR EDWARD CHIEF FINANCIAL OFFICER

  • Officer
400,169 2021-10-08 5

WIDER TODD

  • Director
0 2021-10-07 9

AMOROSO MICHAEL CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
604,637 2021-09-30 6

ROUHANDEH STEVEN H

  • Director
  • 10% Owner
582,674 2021-05-25 2

ALVINO MARK

  • Director
180,349 2021-05-25 2

MANN PAUL ELLIOT

  • Director
87,674 2021-05-25 8

SILVERSTEIN CHRISTINE BERNI

  • Director
167,674 2021-05-25 2

ALLAND LEILA

  • Director
175,349 2021-05-25 2

CHARLES FAITH L.

  • Director
175,349 2021-05-25 2

WUCHTERL DONALD A.

  • Director
175,349 2021-05-25 2

SCO CAPITAL PARTNERS LLC

ROUHANDEH STEVEN H

  • Director
  • 10% Owner
11,079,292 2021-05-03 5

MIGAUSKY GEORGE V

  • Director
0 2020-06-17 0

HOWELL STEPHEN B.

  • Director
97,463 2020-05-20 0

SIFFERT JOAO MD CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
100,000 2020-05-20 0

TOMASELLO SHAWN

  • Director
35,938 2020-05-20 0

BUONO STEFANO

  • Director
287,969 2020-05-20 0

PEREIRA BRIAN JG EXECUTIVE CHAIRMAN

  • Officer
  • Director
0 2020-04-15 0

VAN DUYNE RICHARD B

  • Director
0 2019-05-21 0

MILLER TIMOTHY J SEE REMARKS

  • Officer
0 2019-04-09 0

THIEL CARSTEN CHIEF EXECUTIVE OFFICER

  • Officer
0 2018-03-29 0

THOMPSON STEPHEN B SR VP FINANCE

  • Officer
0 2017-12-14 0

JEFFREY B DAVIS COO

  • Officer
0 2017-12-14 0

AHN MARK J

  • Director
0 2016-12-13 0

ROUHANDEH STEVEN H

SCO CAPITAL PARTNERS LLC

BEACH CAPITAL LLC

  • Director
  • 10% Owner
37,121,279 2014-12-24 0

AYER CAPITAL MANAGEMENT, LP

AYER CAPITAL PARTNERS, LLC

ACM CAPITAL PARTNERS, LLC

VENKATESAN JAY

  • 10% Owner
No longer subject to file 2012-06-28 0

NOWOTNIK DAVID P SR. VP R&D

  • Officer
0 2012-05-24 0

SCO CAPITAL PARTNERS L P

SCO CAPITAL PARTNERS LLC

ROUHANDEH STEVEN H

  • 10% Owner
0 2008-12-18 2

ORACLE INSTITUTIONAL PARTNERS L P

  • 10% Owner
40,165 2008-03-11 0

LUCI DAVID P

  • Director
263,217 2008-02-04 0

ORACLE PARTNERS LP

  • 10% Owner
247,651 2007-11-09 0

ORACLE INVESTMENT MANAGEMENT INC

  • 10% Owner
34,743 2007-11-09 0

FEINBERG LARRY N

ORACLE ASSOCIATES LLC

ORACLE PARTNERS LP

ORACLE INSTITUTIONAL PARTNERS L P

ORACLE INVESTMENT MANAGEMENT INC

  • 10% Owner
13,695,481 2005-02-01 0

ORACLE ASSOCIATES LLC

  • 10% Owner
900,400 2001-07-15 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

SESHADRI VISHWAS - Director - Officer CHIEF EXECUTIVE OFFICER

2021-10-18 16:05:17 -0400 2021-10-15 A 50,000 a 350,000 direct 0.1112 0.1112 2 0.0 1

SESHADRI VISHWAS - Director - Officer CHIEF EXECUTIVE OFFICER

2021-10-18 16:05:17 -0400 2021-10-15 A 300,000 a 300,000 direct

O'MALLEY BRENDAN M. - Officer SVP, GENERAL COUNSEL

2021-10-13 19:08:46 -0400 2021-10-11 S 25,734 $0.90 d 222,510 direct yes 2.1324 1.459 2.1324 2 0.0 1

O'MALLEY BRENDAN M. - Officer SVP, GENERAL COUNSEL

2021-10-08 20:31:59 -0400 2021-10-08 S 22,763 $1.05 d 248,244 direct yes -2.5 -3.1522 0.0 1 -4.3478 3

CARR EDWARD - Officer CHIEF FINANCIAL OFFICER

2021-10-08 20:29:14 -0400 2021-10-08 S 29,122 $1.05 d 400,169 direct yes -2.5 -3.1522 0.0 1 -4.3478 3

WIDER TODD - Director

2021-10-08 20:33:23 -0400 2021-10-07 S 25,000 $0.97 d 0 direct -2.5 -3.1522 0.0 1 -4.3478 3

O'MALLEY BRENDAN M. - Officer SVP, GENERAL COUNSEL

2021-10-08 20:31:59 -0400 2021-10-05 S 2,447 $1.05 d 271,007 direct yes -2.5 -3.1522 0.0 1 -4.3478 3

AMOROSO MICHAEL - Director - Officer CHIEF EXECUTIVE OFFICER

2021-10-04 16:06:05 -0400 2021-09-30 S 45,409 $1.09 d 604,637 direct yes 0.8421 -5.5789 0.8421 2 -5.5789 6

O'MALLEY BRENDAN M. - Officer SVP, GENERAL COUNSEL

2021-09-22 17:37:34 -0400 2021-09-20 A 136,000 a 273,454 direct -3.2787 -8.1967 0.0 1 -9.8361 5

O'MALLEY BRENDAN M. - Officer SVP, GENERAL COUNSEL

2021-09-22 17:37:34 -0400 2021-09-20 A 272,000 a 272,000 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
ABEONA THERAPEUTICS INC ABEO 2021-10-25 22:15:03 UTC -0.9245 0.9945 2200000
ABEONA THERAPEUTICS INC ABEO 2021-10-25 21:45:03 UTC -0.9245 0.9945 2200000
ABEONA THERAPEUTICS INC ABEO 2021-10-25 21:15:03 UTC -0.9245 0.9945 2200000
ABEONA THERAPEUTICS INC ABEO 2021-10-25 20:45:03 UTC -0.9245 0.9945 2200000
ABEONA THERAPEUTICS INC ABEO 2021-10-25 20:15:03 UTC -0.9245 0.9945 2200000
ABEONA THERAPEUTICS INC ABEO 2021-10-25 19:45:04 UTC -0.9245 0.9945 2200000
ABEONA THERAPEUTICS INC ABEO 2021-10-25 19:15:03 UTC -0.9245 0.9945 2200000
ABEONA THERAPEUTICS INC ABEO 2021-10-25 18:45:02 UTC -0.8863 0.9563 2200000
ABEONA THERAPEUTICS INC ABEO 2021-10-25 18:15:03 UTC -0.8863 0.9563 2200000
ABEONA THERAPEUTICS INC ABEO 2021-10-25 17:45:03 UTC -0.8863 0.9563 2200000
ABEONA THERAPEUTICS INC ABEO 2021-10-25 17:15:03 UTC -0.8863 0.9563 2200000
ABEONA THERAPEUTICS INC ABEO 2021-10-25 16:45:02 UTC -0.8154 0.8854 2200000
ABEONA THERAPEUTICS INC ABEO 2021-10-25 16:15:03 UTC -0.8154 0.8854 2200000
ABEONA THERAPEUTICS INC ABEO 2021-10-25 15:45:03 UTC -0.8154 0.8854 2200000
ABEONA THERAPEUTICS INC ABEO 2021-10-25 15:15:03 UTC -0.8154 0.8854 2200000
ABEONA THERAPEUTICS INC ABEO 2021-10-25 14:45:02 UTC -0.9695 1.0395 2200000
ABEONA THERAPEUTICS INC ABEO 2021-10-25 14:15:03 UTC -0.9695 1.0395 2100000
ABEONA THERAPEUTICS INC ABEO 2021-10-25 13:45:03 UTC -0.9695 1.0395 2100000
ABEONA THERAPEUTICS INC ABEO 2021-10-25 13:15:03 UTC -0.9695 1.0395 2100000
ABEONA THERAPEUTICS INC ABEO 2021-10-25 12:45:04 UTC -0.9695 1.0395 1600000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund ABEO -28200.0 shares, $-43992.0 2021-06-30 N-PORT

Elevate your investments